The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trials.

Saved in:
Bibliographic Details
Title: The role of immune checkpoint inhibitors in the first-line treatment for patients with advanced biliary tract cancer: a systematic review and meta-analysis of randomized trials.
Authors: Vitale E; Department of Mental Health, Bari Local Health Authority, Scientific Directorate, IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Rizzo A; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Maistrello L; San Camillo Hospital (IRCCS), Venice, Italy., Nardulli P; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Talienti T; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Quaresmini D; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., De Summa S; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Massafra R; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy., Silvestris N; University of Messina, Messina, Italy., Brunetti O; IRCCS Istituto Tumori 'Giovanni Paolo II', Bari, Italy.
Source: Frontiers in oncology [Front Oncol] 2024 Jul 18; Vol. 14, pp. 1409132. Date of Electronic Publication: 2024 Jul 18 (Print Publication: 2024).
Publication Type: Journal Article; Systematic Review
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Be the first to leave a comment!
You must be logged in first